Qingyangxian Dongbao Modern Agricultural Sightseeing Garden

Following the passing of founder Chen Gongbai in 2021, decision-making authority appears to rest with co-owner Huang Zhen, who holds a 50% stake in the garden company. Huang operates as the family member maintaining both the on-the-ground agricultural operations and the venture LP commitments. The entity does not publish a formal investment committee structure.

The garden and Humanwell Healthcare (Renfu Pharmaceutical) are co-investors in the Shanghai Jianyi Xinghe venture fund. Humanwell is a publicly traded Chinese pharmaceutical company, and the relationship likely stems from the late founder Chen Gongbai's prominence in Chinese academic medicine. The co-investment suggests a deal-sourcing or trust-based alignment between the family office and the corporate healthcare investor.

It is structured as a corporate investor rather than a pure single family office, anchored to a real operating asset — the agricultural sightseeing garden in Qingyang County. This hybrid model means a portion of the entity's capital is tied up in local real estate and tourism operations, while a separate allocation is deployed into third-party venture capital funds alongside institutional co-investors.

The garden commits to funds that cover the full venture lifecycle, from seed and start-up through expansion and late-stage rounds. Its known fund relationships — Shanghai Jianyi Xinghe and Suzhou Zhongding Venture Capital II — are both structured as generalist venture vehicles with multi-stage mandates, managed by Zhongding Capital and its affiliates.

Yes, the Shanghai Zhou Liangfu Medical Development Foundation is affiliated with the same family network. The foundation reflects the legacy of the late founder Chen Gongbai, who was a director at Huashan Hospital and a renowned neurosurgeon. The foundation and the investment entity are operated as separate structures, with the foundation focused on medical development.